121 related articles for article (PubMed ID: 38621151)
1. Clinical Telepharmacy: Addressing Care Gaps in Diabetes Management for an Underserved Urban Population Using a Collaborative Care Model.
Li H; Naqvi IA; Strobino K; Malhotra S
Telemed J E Health; 2024 Apr; ():. PubMed ID: 38621151
[No Abstract] [Full Text] [Related]
2. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
Chung N; Rascati K; Lopez D; Jokerst J; Garza A
J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Outcomes of a Pharmacist-Run, Outpatient Insulin Titration Telepharmacy Service.
Stockton K; Deas C
Innov Pharm; 2019; 10(2):. PubMed ID: 34007540
[TBL] [Abstract][Full Text] [Related]
4. Integrating Innovative Telehealth Solutions into an Interprofessional Team-Delivered Chronic Care Management Pilot Program.
Taylor AM; Bingham J; Schussel K; Axon DR; Dickman DJ; Boesen K; Martin R; Warholak TL
J Manag Care Spec Pharm; 2018 Aug; 24(8):813-818. PubMed ID: 30058982
[TBL] [Abstract][Full Text] [Related]
5. Controlling Blood Pressure During a Pandemic: The Impact of Telepharmacy for Primary Care Patients.
Bruns BE; Lorenzo-Castro SA; Hale GM
J Pharm Pract; 2024 Apr; 37(2):364-368. PubMed ID: 36300296
[No Abstract] [Full Text] [Related]
6. Pharmacist telehealth in an underserved urban population with type 2 diabetes mellitus.
Mukherjee SM; DelDotto D; Patel A; Silva MA
Res Social Adm Pharm; 2023 Nov; 19(11):1465-1470. PubMed ID: 37507339
[TBL] [Abstract][Full Text] [Related]
7. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
[TBL] [Abstract][Full Text] [Related]
8. Survey of the patients' perspectives and preferences in adopting telepharmacy versus in-person visits to the pharmacy: a feasibility study during the COVID-19 pandemic.
Moulaei K; Shanbehzadeh M; Bahaadinbeigy K; Kazemi-Arpanahi H
BMC Med Inform Decis Mak; 2022 Apr; 22(1):99. PubMed ID: 35418072
[TBL] [Abstract][Full Text] [Related]
9. Expansion of Pharmacy Services During COVID-19: Pharmacists and Pharmacy Extenders Filling the Gaps Through Telehealth Services.
Liu C; Patel K; Cernero B; Baratt Y; Dandan N; Marshall O; Li H; Efird L
Hosp Pharm; 2022 Jun; 57(3):349-354. PubMed ID: 35615491
[No Abstract] [Full Text] [Related]
10. Telehealth Access and Substitution in the VHA.
Lum J; Sadej I; Pizer SD; Yee C
J Gen Intern Med; 2024 Feb; 39(Suppl 1):44-52. PubMed ID: 38393611
[TBL] [Abstract][Full Text] [Related]
11. Establishing clinical pharmacist telehealth services during the COVID-19 pandemic.
Segal EM; Alwan L; Pitney C; Taketa C; Indorf A; Held L; Lee KS; Son M; Chi M; Diamantides E; Gosser R
Am J Health Syst Pharm; 2020 Aug; 77(17):1403-1408. PubMed ID: 34279578
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population.
Maxwell LG; McFarland MS; Baker JW; Cassidy RF
Pharmacotherapy; 2016 Mar; 36(3):348-56. PubMed ID: 26877253
[TBL] [Abstract][Full Text] [Related]
13. What Was the Change in Telehealth Usage and Proportion of No-show Visits for an Orthopaedic Trauma Clinic During the COVID-19 Pandemic?
Siow MY; Walker JT; Britt E; Kozy JP; Zanzucchi A; Girard PJ; Schwartz AK; Kent WT
Clin Orthop Relat Res; 2020 Oct; 478(10):2257-2263. PubMed ID: 32639309
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home.
Prudencio J; Cutler T; Roberts S; Marin S; Wilson M
J Manag Care Spec Pharm; 2018 May; 24(5):423-429. PubMed ID: 29694290
[TBL] [Abstract][Full Text] [Related]
15. Demographic Predictors of Telehealth Use for Integrated Psychological Services in Primary Care During the COVID-19 Pandemic.
Tobin ET; Hadwiger A; DiChiara A; Entz A; Miller-Matero LR
J Racial Ethn Health Disparities; 2023 Jun; 10(3):1492-1498. PubMed ID: 35794514
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the primary care clinical pharmacist visit transition to telehealth during the COVID-19 pandemic by comparing medication related problems from telehealth visits and in-person visits.
McNamara A; Zhao M; Lee SY
J Am Coll Clin Pharm; 2021 Aug; 4(8):914-923. PubMed ID: 34518813
[TBL] [Abstract][Full Text] [Related]
17. Telemedicine and health access inequalities during the COVID-19 pandemic.
Datta P; Eiland L; Samson K; Donovan A; Anzalone AJ; McAdam-Marx C
J Glob Health; 2022 Dec; 12():05051. PubMed ID: 36462207
[TBL] [Abstract][Full Text] [Related]
18. Meeting the needs of rural veterans through rapid implementation of pharmacist-provided telehealth management of diabetes during the COVID-19 pandemic.
Baum SG; Coan LM; Porter AK
J Am Pharm Assoc (2003); 2023; 63(2):623-627. PubMed ID: 36379866
[TBL] [Abstract][Full Text] [Related]
19. Telehealth diabetes services for non-English speaking patients.
Hart S; Campbell C; Divine H; Dicks M; Kebodeaux C; Schadler A; McIntosh T
J Am Pharm Assoc (2003); 2022; 62(4):1394-1399. PubMed ID: 35382984
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
